Cannabinoids and opioids share cAMP pathway in rat splenocytes

Journal of Neuroimmunology

Volumn 145, Issue 1-2, 2003, Pages 46-54

  Massi, Paola ^a   Vaccani, Angelo ^b   Rubino, Tiziana ^b   Parolaro, Daniela ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Binding; cAMP signal transduction; Cannabinoids; Interaction; Opioids; Splenocytes

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID DERIVATIVE; CYCLIC AMP; MORPHINE; OPIATE DERIVATIVE; RIMONABANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CROSS REACTIVITY; DRUG INHIBITION; DRUG RECEPTOR BINDING; INTRACELLULAR MEMBRANE; INTRACELLULAR SPACE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPLEEN CELL; SYSTEMATIC DESENSITIZATION; TISSUE SECTION;

EID: 0344872724     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.09.006     Document Type: Article

References (41)

1. Cichewicz D.L., Haller V.L., Welch S.P. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with Δ9-THC and morphine. J. Pharmacol. Exp. Ther. 297:2001;121-127.
2. Devane W.A., Spain J.W., Coscia C.J., Howlett A.C. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. J. Neurochem. 46:1986;1929-1935.
3. Galiègue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
4. Glass M., Felder C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurones: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17:1997;5327-5333.
5. Hauser S.J., Eads M., Embrey J.P., Welch S.P. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Brain Res. 28:2000;337-342.
6. Herring A.C., Faubert Kaplan B.L., Kaminski N.E. Modulation of CREB and NF-kB signal transduction by cannabinol in activated thymocytes. Cell. Signal. 13:2001;241-250.
7. Hilairet S., Bouaboula M., Carriere D., Casellas P. Hypersensitization of the orexin1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR 141716. J. Biol. Chem. 278:2003;23731-23737.
8. Howlett A.C., Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem. Phys. Lipids. 108:2000;53-70.
9. Jan T.R., Kaminski N.E. Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol. J. Leukoc. Biol. 69:2001;841-849.
10. 9- tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kB/ Rel activation. J. Pharmacol. Exp. Ther. 50:1996;334-341.
11. 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinases activation. Proc. Natl. Acad. Sci. 98:2001;343-348.
12. Kaminski N.E., Koh W.S., Yang K.H., Lee M., Kessler F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharmacol. 48:1994;1899-1908.
13. Kaminsky N.E. Regulation of cAMP cascade, gene expression and immune function by cannabinoid receptors. J. Neuroimmunol. 83:1998;124-132.
14. Klein T.W., Newton C., Friedman H. Cannabinoid receptors and immunity. Immunol. Today. 19:1998;373-381.
15. Law P.Y., Wong Y.H., Loh H.H. Molecular mechanism and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40:2000;389-430.
16. Madden J.J., Whaley W.L., Ketelsen D. Opiate binding sites in the cellular immune system: expression and regulation. J. Neuroimmunol. 83:1998;57-62.
17. Manzanares J., Corchero J., Romero J., Fernandez Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interaction between opioids and cannabinoids. TIPS. 20:1999;287-294.
18. Massi P., Patrini G., Rubino T., Fuzio D., Parolaro D. Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. Pharmacol. Biochem. Behav. 58:1997;73-78.
19. Massi P., Fuzio D., Viganò D., Sacerdote P., Parolaro D. Relative involvement of cannabinoid CB1 and CB2 receptors in the delta-9- tetrahydrocannabinol-induced inhibition of natural killer activity. Eur. J. Pharmacol. 387:2000;343-347.
20. Massi P., Vaccani A., Romorini S., Parolaro D. Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects. J. Neuroimmunol. 117:2001;116-124.
21. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62:2001;111-123.
22. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., Del Arco I., Villanua M.A., Maldonado R., Koob G.F., Fonseca F.R. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci. 21:2001;5344-5350.
23. Ni X., Lin B.C., Song C.Y., Wang C.H. Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes. Neuropeptides. 33(2):1999;137-143.
24. Parolaro D., Massi P., Rubino T., Monti E. Endocannabinoids in the immune system and cancer. Prostaglandins, Leukot. Essent. Fat. Acids. 66:2002;319-332.
25. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins, Leukot. Essent. Fat. Acids. 66(2-3):2002;101-121.
26. Pugh G., Welch S.P., Bass P.P. Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol. Biochem. Behav. 49:1993;1093-1100.
27. 9 tetrahydrocannabinol and morphine in the spinal cord. J. Pharmacol. Exp. Ther. 279:1996;608-616.
28. Roda G.L., Bongiorno L., Trani E., Urbani A., Marini M. Positive and negative immunomodulation by opioid peptides. Int. J. Immunopharmacol. 18:1996;1-16.
29. 9-THC- induced antinociceptive tolerance. Pharmacol. Biochem. Behav. 59:1998;399-404.
30. Rubino T., Tizzoni L., Vigano' D., Massi P., Parolaro D. Modulation of rat brain cannabinoid receptors after chronic morphine treatment. NeuroReport. 8:1997;3219-3223.
31. Sacerdote P., Massi P., Panerai A.E., Parolaro D. In vivo and in vitro treatment with the synthetic cannabinoid CP-55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol. 109:2000;155-163.
32. Shapira M., Gafni M., Sarne Y. Independence of, and interaction between, cannabinoid and opioid signal transduction pathway in N18TG2 cells. Brain Res. 806:1998;26-35.
33. Shapira M., Gafni M., Sarne Y. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res. 960:2003;192-200.
34. Sharp B.M., Shahabi N.A., Heagy W., McAllen K., Bell M., Huntoon C., McKean D.J. Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc. Natl. Acad. Sci. 93:1996;8294-8299.
35. Sharp B.M., Roy S., Bidlack J.M. Evidence for opioid receptors on cell involved in host defense and the immune system. J. Neuroimmunol. 83:1998;45-46.
36. 9-tetrahydrocannabinol in mice. Eur. J. Pharmacol. 260:1994;559-566.
37. Upham B.L., Rummel A.M., Carbone J.M., Trosko J.E., Ouyang Y., Crawford R.B., Kaminski N.E. Cannabinoids inhibit gap junction intercellular communication and activate ERK in a rat liver epithelial cell line. Int. J. Cancer. 104:2003;12-18.
38. Vasquez C., Lewis D.L. The CB1 cannabinoid receptor can sequester G-proteins, making then unavailable to couple to other receptors. J. Neurosci. 260:1999;9271-9280.
39. Vigano' D., Cascio M.G., Rubino T., Fezza F., Vaccani A., Di Marzo V., Parolaro D. Chronic morphine modulates the contents of the endocannabinoid, 2-Arachidonoylglycerol, in rat brain. Neuropsychopharmacology. 28:2003;1160-1167.
40. Wager-Miller J.W., Westenbroek R., Mackie K. Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chem. Phys. Lipids. 121:2002;83-89.
41. Whitlock B.B., Liu Y., Chang S., Saini P., Ha B.K., Barrett T.W., Wolfe S.A. Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissue. J. Neuroimmunol. 67:1996;83-96.